Cargando…
CDC20 overexpression predicts a poor prognosis for patients with colorectal cancer
BACKGROUND: The cell division cycle 20 homolog (CDC20) is an essential cofactor of the anaphase-promoting complex (APC/C). CDC20 overexpression has been detected in many types of human cancers; however, its clinical role in colorectal cancer remains unknown. METHODS: Western blotting and immunohisto...
Autores principales: | Wu, Wen-jing, Hu, Kai-shun, Wang, De-shen, Zeng, Zhao-lei, Zhang, Dong-sheng, Chen, Dong-liang, Bai, Long, Xu, Rui-hua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691738/ https://www.ncbi.nlm.nih.gov/pubmed/23758705 http://dx.doi.org/10.1186/1479-5876-11-142 |
Ejemplares similares
-
CDC20 overexpression leads to poor prognosis in solid tumors: A system review and meta-analysis
por: Wang, Shengjie, et al.
Publicado: (2018) -
CDK1 and CDC20 overexpression in patients with colorectal cancer are associated with poor prognosis: evidence from integrated bioinformatics analysis
por: Li, Jianxin, et al.
Publicado: (2020) -
Overexpression of δ-catenin is associated with a malignant phenotype and poor prognosis in colorectal cancer
por: ZHANG, HONG, et al.
Publicado: (2015) -
Cdc42 subcellular relocation in response to VEGF/NRP1 engagement is associated with the poor prognosis of colorectal cancer
por: Ma, Li-li, et al.
Publicado: (2020) -
CDC6, a key replication licensing factor, is overexpressed and confers poor prognosis in diffuse large B-cell lymphoma
por: Shen, Mingfang, et al.
Publicado: (2023)